Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease
Clinical trial NCT06459297 · COMPLETED
Trial details
- NCT number
- NCT06459297
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-24
- Primary completion
- 2025-12-09
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.